New Chancery Challenge Launched To Board-Investor Pacts

By Jeff Montgomery · April 5, 2024, 5:07 PM EDT

A biopharmaceutical company stockholder has teed up a new Delaware Chancery Court suit challenging board-investor voting agreements, with the complaint acknowledging wide debate over the pacts and a fast-moving push to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Jeff

October 21, 2024
Apple Tells Del. Jury It Wants Smartwatch Infringing To Stop
September 06, 2024
Biopharm Co., Directors Sued In Del. Over 'Extreme' Scheme
September 04, 2024
J&J Hit With $1B Damages In Del. Merger Milestone Fight
July 18, 2024
Air Transport Co. Sued In Del. Over Director Removal Rule
July 16, 2024
Chancery Orders Illumina Docs Released In Grail Merger Fight
May 20, 2024
Healthcare Futures Co. Sues Breakaway Ex-Members In Del.
April 05, 2024
Med School Ex-CEO Sues For Legal Fees In Del. After Fraud Suit
February 21, 2024
Del. Suit Accuses Healthcare Data Co. Exec Of Insider Trading
February 06, 2024
Attys Seek $750K Fee In Del. For $6M Med Tech Co. Deal
January 22, 2024
Zantac Class Attys Urge Del. Judge To Keep Experts In Case